At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.17% per year. These returns cover a period from January 1, 1988 through September 4, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
Consequently, upward revisions in estimates express analysts’ positivity towards the company’s business operations and its ability to generate profits. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley fxpcm Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation. Style is an investment factor that has a meaningful impact on investment risk and returns.
Danaher (DHR Quick QuoteDHR – Free Report) closed the latest trading day at $217.23, indicating a +0.17% change from the previous session’s end. Elsewhere, the Dow saw an upswing of 0.87%, while the tech-heavy Nasdaq appreciated by 1.6%. The wall of worry just keeps building, and that leaves investors in a tight spot, says this BNY Mellon strategist.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, octafx broker reviews consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
Shares of the industrial and medical device maker witnessed a loss of 14.93% over the previous month, trailing the performance of the Conglomerates sector with its loss of 9.39% and the S&P 500’s loss of 5.17%. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. The featured stocks all trade at substantial discounts to analyst price targets. The life sciences and diagnostics company’s guidance is getting complicated.
Data may be intentionally delayed pursuant to supplier requirements. Danaher’s stock is owned by many different retail and institutional investors. Top institutional shareholders include National Bank of Canada FI (0.06%), Vontobel Holding Ltd. (0.04%), DnB Asset Management AS (0.04%), Tran Capital Management L.P. Danaher declared a quarterly dividend on Tuesday, September 12th.
Company Summary
A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Danaher caters to various markets, including healthcare, life sciences, diagnostics, environmental monitoring, and industrial automation.
The company underwent several reorganizations and strategic acquisitions, culminating in its present-day structure and diverse product portfolio. High-growth stocks tend to represent the technology, healthcare, and review the signal and the noise communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.
- There’s life after COVID-19 for Danaher, and the stock has a long pathway of growth ahead of it.
- And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
- Its offerings span medical diagnostics equipment, life sciences and diagnostics tools, environmental solutions, water quality analysis systems, industrial automation tools, and other specialized instruments.
- Morningstar analysts hand-select direct competitors or comparable companies to
provide context on the strength and durability of DHR’s
competitive advantage. - In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.
Danaher’s valuation metrics demonstrate positive investor sentiment and confidence in the company’s future growth prospects. Its favorable price-to-earnings ratio and price-to-cash flow ratio reflect investor willingness to pay a premium for its earnings potential and cash generation capacity. Danaher’s stock performance has been noteworthy, driven by its strong financials, strategic initiatives, and positive market sentiment. It is also worth noting that DHR currently has a PEG ratio of 2.34. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account.
Danaher Corp (NYSE:DHR)
By the end of yesterday’s trading, the Diversified Operations industry had an average PEG ratio of 1.81. Analysts and investors alike will be keeping a close eye on the performance of Danaher in its upcoming earnings disclosure. The company’s earnings report is set to go public on October 24, 2023. On that day, Danaher is projected to report earnings of $1.87 per share, which would represent a year-over-year decline of 26.95%. Meanwhile, the latest consensus estimate predicts the revenue to be $6.63 billion, indicating a 13.46% decrease compared to the same quarter of the previous year. The conglomerate has completed the spinoff of its environmental and applied solutions segment into a new company, Veralto.
Recent stocks from this report have soared up to +178.7% in 3 months – this month’s picks could be even better. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes.
16 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Danaher in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “moderate buy” DHR shares.
Danaher has ample growth opportunities, including expansion into emerging markets, strategic acquisitions, and research and development investments. The company’s strong focus on continuous improvement and customer-centric solutions will drive its pursuit of growth opportunities. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.16% decrease. Any recent changes to analyst estimates for Danaher should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends.
These Stocks Moved the Most Today: Newmont, Catalent, Tesla, Tyson, T-Mobile, and More
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. DHR’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600
For example, a price above its moving average is generally considered an upward trend or a buy. The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.
Danaher (NYSE: DHR)
Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. Provides a general description of the business conducted by this company. The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.
Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply. Morningstar analysts hand-select direct competitors or comparable companies to
provide context on the strength and durability of DHR’s
competitive advantage. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Click the link below and we’ll send you MarketBeat’s guide to investing in 5G and which 5G stocks show the most promise.
